Vascular Endothelial Growth Factor (VEGF) has been proposed as a prognostic marker in canine, where it seems to be inversely correlated with survival time [29], while in human meningiomas, it is a tumor recurrence marker [238]. The gene discussed is VEGFA; the disease is neoplasm.